Detailed Narrative
Q4 and FY26 Performance Overview
EMS reported a challenging Q4 FY26 with consolidated revenue of ₹120 crores, a significant decline from the previous year. The full fiscal year 2026 consolidated revenue stood at ₹732 crores, marking a 36-37% year-on-year fall. This underperformance was primarily attributed to external factors rather than strategic missteps, leading to a net profit of ₹6 crores for the quarter.
Impact of External Factors on Revenue
Several external challenges🌐 severely impacted the company's ability to operate at planned capacity. These included delays in obtaining required government permissions, prolonged cash flow constraints from government clients, and project halts due to the West Bengal elections, which alone caused a ₹50 crore shortfall in Q4. Additionally, bitumen supply issues and heavy rainfall in Uttarakhand further delayed road restoration work, impacting billing by ₹30-40 crores.
Inventory Build-up and Payment System Changes
The delays resulted in an increase of approximately ₹100 crores in inventory, representing work in progress where milestones could not be completed. Furthermore, a new government payment system called SPARSH is undergoing a gestation period, causing delays in payments from both central and state governments, which in turn affects payments to subcontractors and project execution.
Order Book and Future Revenue Visibility
As of March 31, 2026, the unexecuted order book stood at a robust ₹1,837 crores. Post-Q4, the company secured additional orders worth ₹209 crores from UP Jal Nigam. Management anticipates securing over ₹1,500 crores in new orders in FY27, with a pipeline of tenders worth ₹2,500-3,000 crores, including bids for Delhi Jal Board and Maharashtra projects. The typical execution timeline for these projects is two to three years.
FY27 Guidance and Long-term Growth Outlook
For FY27, EMS targets a revenue of approximately ₹1,000 crores, aiming to surpass the FY25 figure of ₹966 crores. The company also expects to improve its EBITDA margin from 21% in FY26 to about 25% in FY27, with a PAT margin target of 15%. Despite the current challenges, management remains confident in achieving a long-term revenue CAGR of 20-25% until 2030, emphasizing the vast scope within the urban water and sewage treatment sector.
Capital Allocation and Liquidity
While the company had board approval to raise up to ₹300 crores, management clarified that this was a precautionary measure and there are no immediate plans to raise funds, asserting no stress on the balance sheet. They also committed to steadily reducing pledged shares, aiming for zero by the end of FY27.